MedKoo Biosciences

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to Home

Back to the top

Browse by category

Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Browse products by category


Approved anticancer agents

Anticancer agents in trials

Anticaner agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 


   

Browse products by name

2-methoxyestradiol (angiogenesis inhibitor)

4-demethylpenclomedine(DMPEN) (alkylation agent)

4SC-202 (HDAC inhibitor)

4SC-203 (multi-target kinase inhibitor)

4SC-205 (human kinesin spindle protein Eg5 inhibitor)

A-443654 (AKT inhibitor)

A-674563 (AKT inhibitor)

A-769662 (AMPK activator)

Abarelix

ABC294640 (sphingosine kinase-2 inhibitor)

Abexinostat(PCI-24781; CRA-024781) (HDAC inhibitor)

ABI-008 (nab-docetaxel)

ABI-009 (nab-rapamycin)

ABI-101 (nab-17AAG)

Abiraterone (androgen biosynthesis inhibitor)

Abiraterone acetate (androgen biosynthesis inhibitor)

ABR-215050 (Tasquinimod) (angiogenic inhibitor)

ABT-199 (BCL inhibitor)

ABT-263 (Novitoclax) (Bcl-2 Inhibitor)

ABT-348 (receptor tyrosine kinase inhibitor)

ABT-510 (angiogenesis inhibitor)

ABT-518 (MMP inhibitor)

ABT-737 (BCL-2 inhibitor)

ABT-751 (Microtubule Inhibitor)

ABT-767 (PARP inhibitor)

ABT-806 (anti-EGFR monoclonal antibody )

ABT-828 (a biologic compound that blocks angiogenesis of cancer cells)

AC480 (BMS-599626) (HER inhibitor)

Acadesine (AMP-activated protein kinase activator)

ACE-041 (an investigational protein therapeutic that inhibits angiogenesis)

Aclarubicin hydrochloride

Acolbifene (selective estrogen receptor modulator)

ACY-1215 (HDAC6 inhibitor)

Acyline (MER104) (GnRH antagonist)

AD-1001 (immunomodulatory therapy)

Adenine

Aderbasib (INCB007839) (sheddase inhibitor)

ADI-PEG20 (arginine deiminase (ADI) formulated with polyethylene glycol)

ADPM06 (PDT photosensitizer)

ADW742 (NVP-ADW742) (IGF-IR inhibitor)

AE-37 (Vaccine)

AEE788 (EGFR, ErbB2, KDR, and Flt-1 inhibitor)

AEG-40826 (HGS-1029) (IAP Inhibitor)

AEG-41174 ( tyrosine kinase inhibitor)

AEW-541 (NVP-AEW541) (IGF-IR inhibitor)

AEZS-108 (AN-152) (LHRH-receptor specified doxorubicin conjugate)

AEZS-112 (ZEN012) (tubulin inhibitor)

AEZS-130 (EP-1572) (growth hormone agonist)

AF802 (CH5424802) (ALK inhibitor)

Afatinib (BIBW-2992 ) (EGFR inhibitor)

Afimoxifene (selective estrogen receptor modulator)

AFM-13 (a bispecific, tetravalent human antibody for Hodgkin Lymphoma.)

AFP-464 (aryl hydrocarbon receptor agonist)

AFX-2 (North American ginseng extract)

AFX-9901 (anti-angiogenic agent)

AG-013 (Trefoil Factor)

AG-1478 (EGFR inhibitor)

AG-24322 (CDK inhibitor)

AG-490 (EGFR and JAK inhibitor)

Agomelatine

AI-850 (cremaphor-free formulation of paclitaxel)

AKR-501 (thrombopoietin receptor agonist)

Alanosine (antimetabolic agent; adenylosuccinate synthetase inhibitor)

ALB-109564 ( tubulin inhibitor; antimitotic agent)

Alendronate sodium

Alendronate sodium (geranyltranstransferase inhibitor)

Alfacalcidol

Alisertib (MLN-8237) (Aurora A kinase inhibitor)

Alitretinoin

Allopurinol Sodium

Almestrone

Almorexant

ALN-VSP (an RNAi therapeutic for the treatment of liver cancers )

ALT-801 (IL-2 recombinant fusion protein)

Altretamine

Alvespimycin (Hsp90 inhibitor)

Alvocidib (Flavopiridol) (CDK inhibitor)

Ametantrone (DNA intercalator)

AMG-208 (c-Met inhibitor)

AMG-319 (PI3 Kinase inhibitor )

AMG-337 (c-Met inhibitor)

AMG-386 (angiopoietin inhibitor, an anti-angiopoietin peptibody)

AMG-780 (anti-angiopoietin antibody )

AMG-820 (antibody that targets c-fms and decreases tumor TAM function)

AMG-888 (antibody that inhibits HER3 oncogenic signaling)

AMG-900 (inhibitor of Aurora kinases A, B, and C.)

Amifostine

Aminoglutethimide

Aminolevulinic Acid

Amonafide dihydrohloride (topoisomerase II inhibitor)

Amonafide malate (AS-1413) (topoisomerase II inhibitor)

AMP423 (cyanoaziridine-derivative)

Amrubicin

Amrubicin (anthracycline; DNA intercalactor; topoisomerase II inhibitor)

Amsacrine

Amsalog (topoisomerase II inhibitor)

Amsilarotene (TAC-101) (oral synthetic retinoid)

Amuvatinib (MP-470) (Multitargeted receptor tyrosine kinase inhibitor)

AN-207 (LHRH doxorubicin conjugate)

AN-2728 (PDE4 inhibitor)

ANA-773 (TLR7 agonist)

Anamorelin (RC1291) (ghrelin receptor agonist)

Anastrozole

Aneustat (OMN54) (mixture of extracts from three commonly used Chinese medicine components; Ganoderma lucidum, Salvia miltiorrhiza and Scutellaria barbata)

Anidulafungin

Annamycin (DNA intercalactor; topoisomerase II inhibitor)

ANX-510 (thymidylate synthase inhibitor)

ANX-514 (docetaxel new formulation)

ANZ-207 (cancer vaccine)

AP-26113 (dual ALK and EGFR inhibitor)

Apatinib (VEGFR inhibitor)

Apaziquone (bioreductive prodrug, hypoxia toxic agent)

APC-100 (androgen antagonist)

APC-200 (ROS inhibitor)

APC-300 (signal transduction inhibitor)

Apixaban

APO-866 (FK866) (NAMPT inhibitor)

Aprepitant

Apricoxib (COX-2 inhibitor)

AR-12 (OSU-03012) (PDK-1 inhibitor)

AR-42 (HDAC inhibitor)

Armodafinil (CNS stimulantor)

ARN-509 (androgen receptor antagonist)

Aroplatin (DNA crosslinking agent)

ARQ-092 (AKT inhibitor)

ARQ-501 ( R1668,  beta-lapachone) (DNA damage checkpoint pathway activator)

ARQ-621 (Eg5 inhibitor)

ARQ-736 (BRAF Inhibitor)

ARQ-761 (beta-lapachone prodrug; DNA damage checkpoint pathway activator)

ARRY-300 (MEK inhibitor)

ARRY-380 (HER2 inhibitor)

ARRY-520 (KSP inhibitor)

ARRY-614 (p38 and Tie2 kinase inhibitor)

Arzoxifene (selective estrogen receptor modulators (SERMs))

AS101 (interleukin-10 inhibitor)

AS-605240 (PI3K Inhibitor)

AS703026 (MSC1936369B) (MEK 1/2 inhibitor)

AS703988 (MSC201510B) (MEK 1/2 inhibitor)

Ascomycin

ASP-3026 (ALK inhibitor)

ASP-9521 (17βHSD5 inhibitor)

AT-101(Gossypol acetic acid) (Bcl-2 inhibitor)

AT-13387 (Hsp90 inhibitor)

AT-406 (IAP inhibitor)

AT-7519 (CDK inhibitor)

AT7867 (AKT inhibitor)

AT-9283 (multiple kinase inhibitor)

Ataluren (PTC124) (CFTR-G542X nonsense allele inhibitor)

Atamestane (aromatase inhibitor)

Atazanavir

Atiprimod (STAT3 inhibitor)

ATN-161 (integrin alpha5beta1 inhibitor)

ATN-224 (SOD1 inhibitor)

Atrasentan (ABT-627) (endothelin A receptor antagonist)

AUY-922 (NVP-AUY922,  VER-52296) (Hsp90 inhibitor)

AVL-292 (BTK inhibitor)

AVN-944 (VX-944) (IMPDH inhibitor)

Axitinib (VEGFR inhibitor)

Azacitidine

Azathioprine sodium

AZD1152-HQPA (Aurora B inhibitor)

AZD-1208 (pan-PIM kinase inhibitor)

AZD-1480 (JAK2 inhibitor)

AZD-2014 (mTOR inhibitor

AZD-2461 (PARP inhibitor)

AZD-3514

AZD-4547 (pan-FGFR inhibitor)

AZD-4769 (EGFR tyrosine kinase inhibitor)

AZD-4877 (KSP inhibitor)

AZD-4992

AZD-5363 (PKB/Akt inhibitor)

AZD-5438 (CDK Inhibitor)

AZD-6126 (tubulin Inhibitor)

AZD-6918

AZD-7451 ( TRK inhibitor)

AZD-7762 (checkpoint kinase inhibitor)

AZD-8055 (mTOR inhibitor)

AZD-8330 (ARRY-704)

AZD-8931 (HER1and HER2 inhibitor)

AZM-475271 (Src tyrosine kinase inhibitor)

Bafetinib (INNO-406) (Bcr/Abl inhibitor)

BAL101553 (microtubulin inhibitor)

BAL27862 (microtubulin inhibitor)

Banoxantrone (hypoxia toxic agent)

Barasertib (AZD-1152) (Aurora B inhibitor)

Bardoxolone methyl (RTA402) (antioxidant inflammation modulator)

Batabulin sodium (tubulin inhibitor)

Batimastat (MMP Inhibitor)

BAY 10-00394 ( (CDK inhibitor)

BAY 79-4620 (Antibody–drug conjugate)

BAY 80-6946 (PI3K inhibitor)

BAY 94-9392 (F18 tumor PET imaging agent)

BBI-608 (Cancer cell stemness inhibitor)

BC-819 (a plasmid comprised of the H19 gene regulatory sequences )

Becatecarin (DNA intercalator)

Beclometasone dipropionate (potent glucocorticoid steroid)

Beclomethasone dipropionate

Belinostat (HDAC inhibitor)

Belotecan (camptothecin derivative; topoisomerase I inhibitor)

Bendamustine HCl

Bendamustine HCl (DNA alkylator)

Benoxaprofen

Beraprost (prostacyclin derivative)

Berubicin (topoisomerase II inhibitor; anthracycline derivative)

Besifloxacin

Betamethasone

Betamethasone dipropionate

Bethanechol Chloride

Betulinic acid (  ALS357) (melanoma-specific cytotoxic agent)

Bevonium methylsulfate (also see CG-201) ( hCG inhibitor)

Bexarotene

BEZ235 ( NVP-BEZ235) (PI3K inhibitor)

Bezielle (BZL-101) (extract of plant Scutellaria barbata; apoptosis inducer)

BGC-945 (ONX-0801) (thymidylate synthase inhibitor)

BGJ-398 (pan FGFR kinase inhibitor)

BGT226 (NPV-BGT226) (PI3K inhibitor)

BHQ-880 (Antibody)

BI-2536 (Polo-like kinase 1 inhibitor)

BI-505 (anti-ICAM-1 monoclonal antibody BI-505 )

BI-811283 (Aurora kinase inhibitor)

BI-831266 (temporally not available)

BI-836825 (temporally not available)

BI-847325 (temporally not available)

BI-853520 (focal adhesion kinase inhibitor)

Biapenem

Bicalutamide

BIIB-015 (DM4-conjugated anti-Cripto monoclonal antibody )

BIIB-021 (CNF2024) (HSP90 inhibitor)

BIIB-022 (a human, nonglycosylated IgG4 monoclonal antibody)

BIIB028 (Hsp90 inhibitor)

BIND-014 (PSMA-targeted docetaxel nanoparticles)

Biricodar

BIW-8962 (anti-ganglioside GM2 monoclonal antibod)

BIX02188 (MEK inhibitor)

BIX-02188 (MEK5 inhibitor)

BIX02189 (MEK inhibitor)

BKM-120 (PI3K inhibitor)

Bleomycin sulfate

Blonanserin

BMN-673 (PARP inhibitor)

BMS-275183 (paciltaxel analogue, tubulin inhibitor)

BMS-536924 (IGF-IR kinase inhibitor)

BMS-641988 (androgen receptor (AR) antagonist)

BMS-690514 (VEGFR inhibitor; HER inhibitor)

BMS-754807 (IGF-1R inhibitor)

BMS-777607 (Met tyrosine kinase inhibitor)

BMS-794833 (Met and VEGFR inhibitor)

BMS-833923 (XL-139)

BMS-863233 (XL-413) (CDC7 kinase inhibitor)

BMS-906024 (NOTCH inhibitor)

BMS-911543 (JAK2 inhibitor)

BMS-936558 (an anti-programmed death-1 (MDX-1106))

BMS-936559 (an anti-programmed death-1)

BNC-105 (Vascular disrupting agent, tubulin polymerization inhibitor)

BNC105P (Vascular disrupting agent, tubulin polymerization inhibitor)

Bortezomib

Bosutinib (Abl and Src inhibitor)

BQS-481

Brivanib (VEGFR2 inhibitor)

Brivanib alaninate (VEGFR2 inhibitor)

Brivudin (RP-101)

Brivudine

Brostallicin

BT-062 (Anti-myeloma monoclonal antibody-DM4 immunoconjugate)

BTZ043

Bucillamine

Budesonide

Buserelin

Busulfan

BYL719 (PI3K inhbitor)

C31510 (not available)

Cabazitaxel (XRP6258)

Cabazitaxel (XRP-6258) (tubulin inhibitor)

Cabozantinib ( XL-184) (VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor)

CAL-101 (PI3K inhibitor)

CALAA-01 (siRNA-based cancer drug)

Calcitriol

Canertinib

Canfosfamide

Capecitabine

Capesaris (GTX-758) (estrogen receptor (ER) alpha agonist)

Carbendazim

Carboplatin

Carboquone

Carboxyamidotriazole orotate (CTO)

Carfilzomib (proteasome inhibitor)

Carmofur

Carmustine

Casopitant mesylate

CB-1400 (Not Available)

CBP-501

CC-1088 (selective cytokine inhibitory drug; phosphodiesterase-4 inhibitor)

CC-115 (DNA-PK/TOR kinase inhibitor)

CC-122 (Pleiotropic Pathway Modulator)

CC-223mTOR inhibitor

CC-401

CC-8490

CCT128930 (AKT inhibitor)

CCT-137690 (pan-Aurora kinase inhibitor)

CDB-4124

CDX-011 (antibody-drug conjugate).

CDX-1401 (fusion protein / antibody )

Cediranib (AZD2171) (VEGF inhibitor)

Cefoselis sulfate

Cefsulodine sodium

Celastrol (HSP90 inhibitor)

Celecoxib

Cemadotin

CEP-11981 (VEGFR inhibitor)

CEP-18770 (proteasome inhibitor)

CEP-28122 (Anaplastic Lymphoma Kinase inhibitor)

CEP-7055

CEP-9722 (PARP inhibitor)

Cerovive (NXY-059)

Cevipabulin (antimicrotubule agent)

CF-101

CGC-11047 (PG-11047)

CGS-21680 (adenosine A2A receptor agonist)

CH5132799 (PI3K inhibitor)

CH5424802 (ALK inhibitor)

Chelerythrine chloride

Chidamide  (CS055; HBI-8000)

CHIR-265 (also see: RAF-265)

CHIR-99021

Chlorambucil

Chlorin E6

CHR-2845 (HDAC inhibitor)

CHR-3996 (HDAC inhibitor)

Chrysophanic acid (EGFR/mTOR pathway inhibitor)

CHS-828 (NAD inhibitor)

CI-1040 (also see: PD184352)

Cilengitide

Cinacalcet

Cipatinib (oral tyrosine kinase inhibitor)

Cisatracurium besylate

Cisplatin

CJ-15161

CKD-516 (microtubulin inhibitor)

CKI27 (RG7304) (MEK inhibitor)

Cladribine

Clobetasol propionate

Clodronate disodium

Clodronate disodium

Clofarabine

CLR-1404

CLT-008 (human myeloid progenitor cells)

CNDO-101

CNTO-95 (a fully human monoclonal IgG1 antibody)

CO-101 (Gemcitabine elaidate; CP-4126) (antimetabolite agent)

CO-1686 (AVL-301) (EGFR inhibitor)

Cordycepin (also see: OVI-123)

CP-547632 (VEGFR-2 inhibitor)

CP-724714 (HER2 inhibitor)

CPI-613 (metabolic inhibitor)

CPX-1  (formulation of Irinotecan + Floxuridine)

CPX-351 (formulation of cytarabine + daunorubicin)

Crenolanib (CP-868596) (PDGFR inhibitor)

Crizotinib (PF-2341066)

Crizotinib (PF-2341066) (tyrosine kinase inhibitor)

CRLX-101

Crolibulin (EPC2407)

CRS-100 [a live-attenuated strain of Listeria monocytogenes (Lm)]

CRS-207 [a weakened (attenuated) form of Listeria monocytogenes]

CST-101 (the native NK-92 cell-line)

CT-011 (a humanized monoclonal antibody (mAb) that modulates the immune response and inhibits tumor growth and the spread of metastases.)

CUDC-101 (HDAC, EGFR and HER2 inhibitor)

Custiren (TV-1001, OCX-011) [a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties.]

CV9103 (mRNA-derived prostate cancer vaccine)

CVT-6883 (A2B adenosine antagonist)

CWP232291 (Wnt signaling inhibitor)

CX-5461 (RNA polymerase I Inhibitor)

CYC-116 (Aurora kinase/VEGFR2 inhibitor)

Cyclophosphamide

Cyproterone acetate

CYT-107 (Interleukin-7)

CYT-387 (JAK inhibitor)

CYT-6091 (a nanotherapeutic manufactured by covalently linking tumor necrosis factor-a (TNF) onto the surface of 30 nm particles of pegylated colloidal gold)

Cytarabine

D-3263

Dabigatran Etexilate

Dabrafenib (GSK-2118436) (B-RAF inhibitor)

Dacarbazine

Dacinostat (NVP-LAQ824)

Dacomitinib (PF-00299804) (EGFR inhibitor)

Dactinomycin

Danoprevir

Danusertib (PHA-739358) (Aurora kinase inhibitor)

Daptomycin

Darinaparsin (ZIO-101)

Darunavir

Dasatinib

Daunorubicin

DCC-2036 (BCR-ABL inhibitor)

Debio-0932 (CUDC-305) (Hsp90 inhibitor)

Decitabine

Deflazacort

Degarelix acetate

Degarelix acetate

Demecarium bromide

Denibulin (MN-029)

Desmopressin Acetate

Desonide

Dexamethasone

Dexmethylphenidate

Dexrazoxane Hydrochloride

Diaziquone

Dienogest

Diethylnorspermine

Diflomotecan

Diflorasone

Dimebone HCl 

Dimesna

Dinaciclib (SCH-727965, PS-095760) (CDK inhibitor)

DJ-927 (Tesetaxel )

DMPEN(4-demethylpenclomedine) (alkylation agent)

Docetaxel

Docosahexaenoic acid

Dofequidar

Doramapimod (p38 MAPK inhibitor)

Dorzolamide hydrochloride

Dovitinib (TKI-258,  CHIR258) (fibroblast growth factor receptor 3 (FGFR3) inhibitor)

Doxercalciferol 

Doxifluridine

Doxorubicin Hydrochloride

Dromostanolone Propionate

Droxinostat (HDAC inhibitor)

DS-2248

DS-7423 (PI3K/mTOR kinase inhibitor)

Dutasteride

Dutasteride

E-3810 (VEGFR/FGFR dual kinase inhibitor)

E6201 ( MEK-1/MEKK-1 inhibitor)

E7016 (PARP inhibitor)

E7050 ( c-Met/VEGFR kinase inhibitor)

E7272 (also see : ONTAK or denileukin diftitox)

E7820 (angiogenesis inhibitor)

E7974

EC-0225

 EC-0489

EC-145

EC-17

EC-20 (tumor imaging agent)

ECC-33 (RG7686) [monoclonal antibody]

Edatrexate

Edotecarin (PHA-782615; J-107088; ED-749) (topoisomerase inhibitor)

Efaproxiral (radiosensitizer)

Eflornithine (CPP-1X)

EGEN-001 [non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12)]

EGEN-002 [not available]

Elacridar (P-glycoprotein inhibitor)

Elacytarabine (antimetabolite agent)

Elagolix ( NBI-56418)

Elesclomol (HSP-90 Inhibitor)

Elinafide (DNA intercalator)

Elisidepsin (PM-02734)

Elomotecan (BN-80927) (topoisomerase inhibitor)

Elsamitrucin (DNA intercalator)

Eltrombopag

Eltrombopag (thrombopoietin receptor agonist)

EMD-1204831 (c-MET inhibitor)

EMD-1214063 (c-Met inhibitor)

Eniluracil (dihydropyrimidine dehydrogenase inhibitor)

ENMD-1198 (antimitotic agent)

ENMD-2076 (Aurora kinase inhibitor)

Entecavir

Entinostat (MS-275,  SNDX-275) (HDAC inhibitor)

Enzastaurin (LY317615) (protein kinase C beta inhibitor)

EP-100 [an LHRH receptor-targeting ligand conjugated to a novel
membrane-disrupting peptide called CLIP 71.]

Epirubicin hydrochloride

Epofolate (BMS-753493) (folate receptor-targeting antimitotic agent)

Epothilone D ) (tubulin inhibitor)

Eribulin mesylate (E7389)

Eribulin mesylate (E7389) (tubulin inhibitor)

Erismodegib (LDE225, NVP-LDE225) (Smo antagonist)

Erlotinib Hydrochloride

Ertapenem sodium 

ES285

Estramustine phosphate sodium

Estriol

Estrone

Etalocib (LY293111) (LTB4 receptor antagonist)

Ethinyl Estradiol

Ethonafide

Ethynylcytidine

Etoposide

Etoposide Phosphate

Everolimus

Everolimus

Exatecan (topoisomerase inhibitor)

Exemestane

Exherin

Exisulind

Ezatiostat (glutathione S-transferase P1-1 (GSTP1-1) inhibitor)

EZN-2208 (Pegylated SN-38)

Fenretinide (RAR agonist)

Fentanyl

Finasteride

Fingolimod

Floxuridine

Fluciclatide F-18

Fludarabine

Fludarabine phosphate

Flumethasone

Fluorogestone acetate

Fluorometholone acetate

Fluorouracil

Flutamide

Foretinib (XL880, SK1363089, GSK089, EXEL-2880) (MET/VEGFR2 inhibitor)

Formestane

Formylmelphalan

Forodesine

Fosaprepitant

Fosaprepitant  (antiemetic agent)

Fosbretabulin (combretastatinA-4phosphate, CA4P) (vascular disrupting agent)

Fostamatinib (R788) (Syk kinase inhibitor)

Fotemustine

FT-1050 (Stem Cell Modulator)

Fulvestrant  

Galeterone (TOK-001)

Ganciclovir

Ganetespib (STA-9090) (Hsp90 inhibitor)

GANT58 (Hedgehog inhibitor)

GDC-0032 (PI3K inhibitor)

GDC-0068 (AKT inhibitor)

GDC-0152 (IAP inhibitor, Smac mimetic)

GDC-0425 (RG7602) (ChK-1 inhibitor)

GDC-0623 (MEK inhibitor)

GDC-0879 (B-Raf Inhibitor)

GDC-0917 (IAP inhibitor)

GDC-0941 (PI3K inhibitor)

GDC-0973 (XL518) (MEK inhibitor)

GDC-0980 (RG7422) ( PI3 kinase/mTOR inhibitor)

Gefitinib

Gemcitabine Hydrochloride

GENZ-644282

GFB-204 (VEGFR and PDGFR inhibitor)

GGTI-2418 (geranylgeranyltransferase I inhibitor)

GI-4000 (Targeted Molecular Immunogen)

GI-6207 (vaccine)

Gimatecan (topoisomerase inhibtor)

Ginsenoside Rb1

Ginsenosides Ro

Givinostat (ITF2357) (HDAC inhibitor)

GLPG0187 (integrin receptor antagonist)

Glufosfamide

Glutathione

Glyciphosphoramide

Glyfosfin

GO-203-2C (MUC1-targeted peptide)

Golotimod

Goserelin Acetate

Gossypol (Bcl-2 inhibitor)

GPI-15427

GPX100 (anthracycline, DNA intercalator)

GPX150 (anthracycline, DNA intercalator)

Granisetron hydrochloride

GRN-1005 (ANG-1005) (paclitaxel conjugate, microtube inhibitor)

GS-9219

GSK-1059615 (mTOR inhibitor

GSK-1070916

GSK-1070916A

GSK-1292263 (GPR119 receptor agonist )

GSK-1904529a (IGF-1R Inhibitor)

GSK-2110183 (AKT inhibitor)

GSK-2126458 (PI3K inhibitor, mTOR inhibitor)

GSK-2141795 (Akt inhibitor)

GSK-2256098

GSK-2401502

GSK-2586881 (APN01)

GSK-2636771 (PI3K inhibitor)

GSK-461364 (PLK Inhibitor)

GSK-690693 (pan-Akt kinase inhibitor)

Gusperimus (immunosuppressant agent)

GW788388 (TGF-beta inhibitor)

HA14-1

Halobetasol propionate

HE-3235

Henatinib (multitargeted tyrosine kinase inhibitor)

Heptaplatin

Hesperadin

Hexyl 5-aminolevulinate

Histrelin Acetate

HM30181 (MDR1 inhibitor)

HM30181 (MDR1 inhibitor)

HM781-36B (irreversible pan-HER inhibitor)

HMN-176 (PLK-1 inhibitor)

HMN-214 (PLK-1 inhibitor)

HQK-1004

HSP-990 (HSP inhibitor)

Hycanthone (Topoisomerase inhibitor, DNA intercalator)

Hydroxytyrosol

Hypothemycin

Iboctadekin (immunostimulatory cytokine )

Ibutamoren

Icotinib (EGFR inhibitor)

Icotinib (EGFR inhibitor)

Idarubicin HCl

Ifosfamide

Iguratimod

Imatinib Mesylate

Imetelstat  (GRN-163L)

Imexon (caspase inhibitor)

IMGN-388 (Targeted Antibody Payload, TAP)

IMGN-901 (lorvotuzumab mertansine)

Imidazoacridone

IMO-2055 (EMD1201081)

INC280 (INCB-028060) (c-MET inhibitor, RTK inhibitor)

INCB-24360

Incyclinide

Indibulin (ZIO-301) (tubulin inhibitor)

Indisulam (carbonic anhydrase inhbitor)

Ingenol Mebutate (PEP005)

Iniparib (BSI-201) (PARP inhibitor)

INK-1117 (PI3K inhibitor)

INK-128 (mTOR inhibitor)

INNO-206 (DNA intercalating agent)

INO-1001

Inolitazone (CS-7017, Efatutazone )

INSM-18

Iobenguane

Iobenguane

Ioflubenzamide I-131 (MIP-1145)

IPH-2101 (human anti-NK-cell inhibitory receptor mAb)

IPI-145 (INK-1197) (PI3K inhibitor)

IPI-269609 (Hedgehog pathway inhibitor)

IPI-493

IPI-926 (Hedgehog pathway inhibitor)

Irinotecan Hydrochloride

Irofulven

Irosustat (STX64, BN83495)

Isatoribine (toll-like receptor 7 (TLR-7) agonist)

ISF-35 (vaccine)

Iso-Fludelone (microtubulin inhibitor)

Ispinesib

Istradefylline

Ixabepilone

Ixabepilone

Ixazomib (MLN-9708) (the first oral proteasome inhibitor)

JI-101

JNJ-26481585 (HDAC inhibitor)

JNJ-26483327

JNJ-38877605 (tyrosine kinase inhibitor)

JNS002 (Pegylated liposomal doxorubicin)

JX-594 (thymidine kinase-deleted vaccinia-hGM-CSF)

JX-929 (A highly tumor-selective vaccinia virus )

Kahalalide F

Karenitecin (Cositecan, BNP-1350).

KB-004 (Humaneered™ monoclonal antibody)

Ketamine

Ketamine

KHK-2866 (Anti-HB-EGF Antibody)

KOS-1584 (R1645)

KP372-1 (Akt inhibitor)

KRN5500

KRN7000 (RGI-2001) (immunomodulator)

KRP-203 (Sphingosine-1-phosphate receptor agonist)

KRX-0402

KRX-0601(also see UCN-01)

KU-0063794 (mTOR inhibitor)

KU-55933

KW-2449

KW-2478 (Hsp90 inhibitor)

KX2-391 (rc kinase inhibitor)

Lacosamide

Lanreotide acetate

Lansoprazole

Lapatinib

Laromustine(VNP40101M)

Larotaxel (XRP9881)

Lasofoxifene

Lasofoxifene

LCL-161

LDK-378 (ALK inhibitor)

LDN-193189

LE-DT (Liposome Encapsulated Docetaxel)

LEE-011

Lemuteporfin (QLT-0074) (PDT photosensitizer)

Lenalidomide

lenvatinib (E7080)

LEP-ETU (liposomal paclitaxel, PNU-93914)

LEQ-506

Lestaurtinib

Letrozole

Leucovorin Calcium

Leuprolide Acetate

Levamisole Hydrochloride

Levocetirizine

Levoleucovorin Calcium

Levoleucovorin Calcium

lexibulin (CYT997) (Vascular disrupting agent)

LGD-4665

LGH447

LGK-974

LGX818 (Raf kinase inhibitor)

Linifanib ( ABT869) (RTK inhibitor)

Linsitnib (OSI-906) (IGF-1R inhibitor)

Lisdexamfetamine dimesylate

Litronesib (aslo see: LY2523355)

Lobaplatin

Lomeguatrib

Lomustine

Lonafarnib (farnesyl transferase inhibitor)

LOR-253 (MTF-1 inhibitor)

LOR-500 (MELK inhibitor)

LP-261

Lucanthone (Topoisomerase inhibitor, DNA intercalator)

Lurtotecan (OSI-221; NX221) (topoisomerase I inhibitor)

LW6 (HIF-1α inhibitor)

LY2090314 (GSK-3 inhibitor)

LY2157299 (TGF-βR inhibitor)

LY2181308 (antisense oligonucleotide)

LY2228820 (p38MAPK inhibitor)

LY2334737 (antimetabolite agent)

LY2584702

LY2603618 (CHK2 inhibitor)

LY2606368

LY2624587 (not available)

LY2780301 (AKT inhibitor)

LY2801653 (c-MET inhibitor)

LY2874455 (FGFR inhibitor)

LY2875358 (anti-c-MET monoclonal antibody)

LY294002 (PI3K inhibitor)

LY2940680

LY3007113 (p38 MAPK inhibitor)

LY475776 (P-glycoprotein inhibitors)

M40403

Marimastat (BB-2516)

Marizomib (NPI-0052) (proteasome inhibitor)

Masitinib (AB1010) (tyrosine kinase inhibitor)

Masoprocol (NDGA) (lipoxygenase inhibitor)

Maytansine (microtubule inhibitor)

MB07133

MDV3100 (selective androgen receptor modulator)

ME-143 (NV-143) (NADH oxidase inhibitor)

ME-344 (mTOR1/2 kinase inhibitor)

Mechlorethamine Gel

Mechlorethamine Hydrochloride

Megestrol Acetate

MEK-162 (ARRY-162) (MEK1/2 inhibitor)

Melphalan Hydrochloride

Meprednisone

Mercaptopurine

Meropenem 

Mesna

Mesupron (WX-671)

Methotrexate

Methoxsalen

Methoxyamine (TRC102) (DNA base excision repair (BER) inhibitor)

Methyl aminolevulinate

Methyl aminolevulinate  (PDT photosensitizer)

Methylene Blue

Methylisoindigotin

Methylprednisolone acetate

MG-516 (multi-targeted kinase inhibitor)

MGCD-265 (multitargeted tyrosine kinase inhibitor)

Midostaurin (PKC412)

Mifamurtide

Mifamurtide (L-MTP-PE. MTP-PE) (immunomodulatory agent)

Mifepristone

Milataxel

Milciclib (PHA-848125) (CDK inhibitor and TRKA inhibitor)

Miltefosine

Minoxidil

MINT-1526A (An anti-murine integrin α5β1 antibody)

MIP-1095

Mitobronitol

Mitomycin C

Mitotane

Mitoxantrone hydrochloride

MK-0429 (ανβ3 Integrin Inhibitor)

MK-0731 (KSP inhibitor)

MK-0752 (notch inhibitor)

MK-1496 (Polo-like kinase 1 inhibitor)

MK-1775 (WEE inhibitor)

MK-2206 (Akt inhibitor)

MK-2461 (Multitargeted Kinase Inhibitor)

MK-4101 (not available)

MK-4827 (PARP inhibitor)

MK-5108 (VX-689)

MK-5172 (protease inhibitor)

MK-8033 (c-MET inhibitor)

MK-8245 (a stearoyl-CoA desaturase (SCD) inhibitor)

MKC-1

MKC1106-PP (immunotherapy)

MKI-833

MLN-2238 (oral proteasome inhibitor, metabolite of MLN9708)

MLN-2480 (Raf kinase inhibitor)

MLN-4924

MLN-8054 (aurora kinase inhibitor)

MM-111 (a bispecific antibody)

MM-151 (EGFR inhibitor)

MM-302 (doxorubicin nanotherapy)

MM-398 (irinotecan nanotherapy)

MN-201

Mocetinostat (MGCD-0103) (HDAC inhibitor)

Mometasone furoate

Motesanib (AMG-706) (tyrosine kinase inhibitor)

Motexafin gadolinium (PDT photosensitizer, radiosensitizer)

Motexafin lutetium (PDT photosensitizer, radiosensitizer)

Moxifloxacin HCl

MP-412 (AV-412) (EGFR/HER2 tyrosine kinase inhibitor)

MPC-2130

MPC-3100 (Hsp90 inhibitor)

MRX-1024

MSX-122

MT-110 (a Bispecific T cell Engager (BiTE)® antibody)

Mubritinib (TAK-165) (EGFR inhibitor)

Muparfostat (PI88, heparin sulfate)

MVA-5T4 (attenuated modified Vaccinia Ankara virus)

Myrsinoic acid A

Nabiximols

Nabiximols

Nafarelin

Nandrolone

NBI-42902

Nedaplatin

Nelarabine

Nemorubicin

Nepafenac

Neratinib (HKI272) (HER2 and EGFR inhibitor)

Nilotinib

Nilotinib (Bcr-Abl inhibitor)

Nilutamide

Nimustine

NintedanibBIBF-1120) (VEGFR inhibitor)

Nitroarginine (NG-nitro-L-arginine) (nitric oxide synthase inhibitor)

NK-012 (SN-38-PEG conjugate, camptotecin conjugate)

NKP-1339 (ruthenium-based transferrin targeting agent)

NKP-2235 (gallium-based small molecule)

NKTR-102

NKTR-105

NM-3 (isocoumarin)

NMS-1116354 (CDC7 kinase inhibitor)

NMS-1286937 (PLK1 inhibitor)

Nocodazole 

Nolatrexed

Norepinephrine

Noscapine (also see CB-3304)

NOV-002 (chemoprotective agent)

Novitoclax (ABT-263) (Bcl-2 Inhibitor)

NRX-4204

NS-018 (JAK2/Src inhibitor)

NTX-10 (vaccine)

NV-1020 (oncolytic herpes simplex virus type 1)

NV-128 (mTOT inhibitor)

NVP-AEW541 ( AEW541)

NVP-BEP800 (BEP800) (Hsp90 inhibitor)

Obatoclax (  GX15-070) (BCL-2 Inhibitor)

Oblimersen (bcl-2 antisense oligodeoxynucleotide G3139)

OBP-301 (Telomerase-Specific Replication-Competent Adenovirus)

Octreotide

OCV-501

OCX-011 (Custiren, TV-1001) [a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties.]

Odanacatib (MK-0822) (protease inhibitor)

ODM-201

Oglufanide

OGX-427 (Hsp27 antisense oligonucleotide )

Olaparib (AZD-2281) (PARP inhibitor)

Oleandrin (PBI-05204)

Omacetaxine mepesuccinate (Homoharringtonine)

Omacetaxine mepesuccinate (Homoharringtonine)

Ombrabulin (AVE8062) (tubulin inhibitor)

Omtriptolide

ON-013105

Ondansetron hydrochloride

ONT-093 (OC144-093)

ONX 0805 (SB1578)

ONX-0912 (proteasome inhibitor)

ONX-0914 (immunoproteasome inhibitor)

OPB-31121 (STAT3 inhibitor)

OPB-51602 (STAT3 inhibitor)

Ortataxel

Orteronel (TAK-700) (steroid 17alpha-monooxygenase inhibitor)

OSI-027 (mTOR inhibitor)

OSI-420 (CP-473420) ( EGFR inhibitor )

OSI-7904L(also see: GS7904L, OVI-237 )

OSI-906 (Linsitnib) (IGF-1R inhibitor)

OSI-930

Ostarine (MK-2866, GTX-024)

Oxaliplatin

OXi-4503

Ozarelix (also see: SPI-153)

P2045

P276-00 (DCK inhibitor)

PA799 (PI3K class I inhibitor)

Paclitaxel

Pacritinib (SB1518)

Padeliporfin (WST11, Stakel) (PDT photosensitizer)

Padoporfin (Tookad) (PDT photosensitizer)

Palifosfamide (ZIO-201)

Palomid 529 (PI3K inhibitor; Akt inhibitor; mTOR inhibitor)

Palonosetron hydrochloride

Pamidronate Disodium

Panobinostat (NVP-LBH589; LBH589) (HDAC inhibitor)

Pasireotide (SOM-230) ( somatostatin receptor agonist)

Patupilone (EPO906)

Pazopanib (GW786034) (tyrosine kinase inhibitor )

Pazopanib Hydrochloride (GW786034)

PCI-27483 (factor VIIa inhibitor)

PCI-32765 (BTK inhibitor)

PD-0325901 (MEK inhibitor)

PD-0332991 (CDK Inhibitor)

PD098059 (MEK inhibitor; MAP kinase inhibitor)

PD-153035 (EGFR inhibitor)

Pelitinib (EKB569) (pan-ErbB tyrosine kinase inhibitor)

Pelitrexol (GARFT inhibitor) (glycinamide ribonucleotide formyltransferase)

Pemetrexed Disodium

Pentostatin

Peplomycin

Peramivir

Pergolide

Perifosine (AKT Inhibitor)

PF-03084014

PF-0337210

PF-03446962 (anti-ALK-1 monoclonal antibody)

PF-03732010 (antibody drug, p-cadherin antagonist)

PF-03758309 (PAK4 inhibitor)

PF-04217903 ( MET tyrosine kinase inhibitor)

PF-04449913

PF-04554878 (FAK inhibitor)

PF-04605412 (anti-A5B1 integrin monoclonal antibody )

PF-04691502 (PI3K/mTOR inhibitor)

PF-0477736

PF-04856884 (CVX-060) [the fusion of two Ang2 sequestering peptides]

PF-0562271 (PF-562271; PF-00562271) (a FAK inhibitor)

PF-3845 (a FAAH Inhibitor)

PHA-665752 (c-MET inhibitor)

Phenoxodiol

Photochlor (PDT photosensitizer)

PHT-427 (Akt inhibitor)

PHY-906

PI-103 (PI3K inhibitor, and mTOR inhibitor)

Picoplatin

Picropodophyllin (AXL1717) (IGF-1 receptor inhibitor)

PIK-75 (PI3K inhibitor)

Pimavanserin

Pimecrolimus

Pipendoxifene

Pipobroman

Pirarubicin

Piroxantrone (topoisomerase II inhibitor)

Pixantrone

PKI-587 (PF-05212384)

Plerixafor

Plerixafor

Plevitrexed (BGC-9331)

Plicamycin

Plinabulin (NPI-2358)

Plitidepsin (Aplidine)

PLX-3397 (multitargeted tyrosine kinase inhibitor)

PLX-4720 (B-Raf inhibitor)

PM-00104

PM-01183

PM-060184

PN-401

PNT-2258 (an oligonucleotide therapeutic encapsulated within a SMARTICLES formulation).

PNU-93914 (liposomal paclitaxel, LEP-ETU)

POL6326 (CXCR4 inhibitor)

Polymyxin B sulphate

Polyphenon E

Pomalidomide

Ponatinib (AP-24534) (tyrosine kinase inhibitor)

Porfimer Sodium

Porfiromycin

PP242 (mTOR inhibitor)

PP-242 (mTOR inhibitor)

PPI-2458

PR-104

Pracinostat (SB939) (HDAC inhibitor)

Pralatrexate

Pralatrexate (dihydrofolate reductase inhibitor)

Prasugrel

Prednimustine

PRI-724 (CBP/beta-catenin antagonist; Wnt signaling pathway inhibitor)

Prinomastat

PRLX-93936

Procarbazine Hydrochloride

PRT-062607

Prucalopride

PRX-302 (protein drug)

PTC-299 (VEGF inhibitor)

Pterostilbene

PTI-188 (a radiolabeled murine anti-melanin antibody)

PU-H71 (Hsp90 inhibitor)

PV-10

PWT33597 (PI3K inhibitor)

PX-12

PX-478 (HIF-1alpha inhibitor)

PX-866 (PI3K inhibitor)

Pyropheophorbide derivatives

Pyroxamide

PZP115891

QBI-139 (protein drug)

Quarfloxin (CX-3543) (G-quadruplex-interactive agent)

Quinacrine (Mepacrine ; CBLC102)

Quinagolide (D2 receptor agonist)

Quinagolide hydrochloride

Quizartinib (AC220) (FLT3 inhibitor)

R1530 (Mitosis-angiogenesis inhibitor)

R306465

R547

R763 (AS703569) (Aurora kinase inhibitor)

Raloxifene

Raltegravir 

Raltitrexed

Ramelteon

Ramoplanin

Ranimustine

RC3095

RDEA-436 (MEK inhibitor)

Refametinib (RDEA119; BAY86-9766) (MEK inhibitor)

Regorafenib (BAY 73-4506) (oral multi-kinase inhibitor)

Relacatib

Resiquimod (Toll-like receptor (TLR) agonist)

Resminostat (4SC-201) (HDAC inhibitor)

Resveratrol

Resveratrol(RM1812 , SRT-501)

Retapamulin

Retaspimycin (IPI504) (HSP90 inhibitor)

Retigabine

RG-7167 (MEK inhibitor)

RG-7347 (MNRP1685, R7347, Anti-NRP1)

RG7593 (anti-CD22-MCC-MMAE)

RG7594 (antibody drug)

RG7686 (ECC-33) [monoclonal antibody]

RH1

Ridaforolimus (Deforolimus)

RigosertibON-01910 ) (PLK1 inhibitor)

Rindopepimut (immunotherapy, vaccine)

Riociguat

Rivaroxaban

RM1812 (resveratrol, SRT-501)

RO4929097 (R4733) (gamma-secretase/Notch signalling pathway inhibitor)

RO4987655 (MEK inhibitor)

RO5045337 ( RG7112, R7112) (MDM2 (human homolog of double minutes-2; HDM2) antagonist)

RO5126766 (Raf/MEK dual kinase inhibitor)

RO518426 (V600E BRAF Blocker)

RO5212054 (PLX3603, RG-7256) (BRAF(V600E) kinase inhibitor)

RO5503781 (MDM2 antagonist)

Roflumilast

Rolapitant

Romidepsin

Ropidoxuridine

Roquinimex

Rosabulin

Rostaporfin (PDT photosensitizer)

RRX-001 (radiosensitizer)

Rubitecan

Rucaparib (PF-01367338, AG-14699) (PARP1 inhibitor)

Rufinamide

Ruxolitinib (INC-424; INCB-18424) (JAK1 inhibitor)

Ruxolitinib (JAK1 inhibitor)

RX-0201 (Akt antisense oligonucleotide)

S31-201

Sabarubicin (DNA intercalator)

Sagopilone (ZK epothilone)

Salirasib

Sapacitabine

SAR103168

SAR256212 (MM-121, human monoclonal antibody)

SAR307746 (REGN901, anti-ANG2 monoclonal antibody)

SAR3419

SAR411298 (FAAH inhibitor. Cancer pain)

Saracatinib (AZD-0530) (Src and Abl inhibitor)

Sardomozide

Sarsasapogenin

Satraplatin

Saxagliptin

SB-1518 (JAK2 inhibitor)

SB202580 (MEK inhibitor; MAP kinase inhibitor)

SB-216763 (glycogen synthase kinase-3 (GSK-3) inhibitor)

SB-431542 (TGF-beta receptor inhibitor, ALK inhibitor)

SB-743921 (KSP inhibitor)

SCH900353

SCH900776 (Chk1 inhibitor)

Seliciclib (CDK inhibitor)

Selumetinib (AZD-6244) (MEK 1/2 inhibitor)

Semagacestat

Semapimod

Semustine

Seocalcitol (CB1089)

Serdemetan (JNJ-26854165)

SF1126

SGI-110

SGI-1776 (pan-Pim protein kinase inhibitor)

SGN-75 (anti-CD70 monoclonal antibody)

SGX-523 (Met Inhibitor)

SHP-141 (HDAC inhibitor)

Silatecan (AR-67; DB-67) (topoisomerase I inhibitor; camptotecin derivative)

Silibinin ( extract of the milk thistle seeds; mixture of flavonolignans)

Silmitasertib (CX-4945) (CK2 inhibitor)

Simotaxel

Sirolimus

Sirolimus

Sitagliptin

Sivifene

SJG-136 (BN2629, SG2000) (DNA replication inhibitor)

SL-401 (human IL3 recombinantly conjugated to diphtheria toxin).

SN-2310 (SN-38 conjugate with VE; topoisomerase I inhibitor)

SNS-032 (BMS-387032) (CDK inhibitor)

SNS-314 (Aurora kinase inhibitor)

SNX-2112 (HSP90 inhibitor)

SNX-5422 (PF-4929113)

Soblidotin (tubulin polymerization inhibitor)

Sonoflora 1 ( SF1) (PDT photosensitizer)

Sorafenib

Sotatercept (ACE-011, human fusion protein )

Sotrastaurin (AEB071) (PCK inhibitor)

SPI-1005 (ebselen-containing oral capsule)

SPI-1620

Squalamine

SR13668 (Akt inhibitor)

SR-31747 (Peripheral sigma receptor antagonist)

SSR97225

STA-1474 (Prodrug of ganetespib) (HSP90 inhibitor)

Stannsoporfin (heme oxygenase inhibitor)

Streptozocin

SU14813

Sufentanil (ARX-02)

Sulforaphane (natural antioxidant)

Sunitinib

SYM-004 (anti-EGFR monoclonal antibody mixture)

SYP-0704A

Tacrolimus

TAE684 (NVP-TAE684) (ALK Inhibitor)

TAK-285 (HER2/EGFR dual kinase inhibitor)

TAK-441 (Hedghog inhibitor)

TAK-448

TAK-593 (VEGFR/PDGFR dual kinase inhibitor)

TAK-683

TAK-701 (anti-HGF monoclonal antibody)

TAK-733 (MEK inhibitor)

TAK-901 (Aurora B kinase inhibitor )

TAK-960 (PLK1 inhibitor)

Talabostat

Talampanel (AMPA-receptor antagonist)

Talaporfin sodium

Talaporfin sodium (PDT photosensitizer)

Talotrexin Ammonium

Taltobulin (tubulin inhibitor)

Tamibarotene

Tamibarotene (retinoic acid receptor (RAR) alpha/beta agonist)

Tamoxifen Citrate

Tandutinib (MLN0518) (tyrosine kinase inhibitor)

Tanomastat (matrix metalloprotease inhibitor)

Tapentadol

Tapentadol

Tarenflurbil ((NSAID drug, enantiomer of flurbiprofen)

Tariquidar (p-glycoprotein inhibitor)

TAS-102

TAS-103 (BMS-247615)

TAS-108 (estrogenic receptor alpha (ERa) inhibitor)

TAS-109 (DNA polymerase inhibitor)

TAS266 (tetrameric Nanobody® agonist)

Tasidotin

Tasisulam (LY573636)

Tasquinimod (ABR-215050) (angiogenic inhibitor)

Tegafur

Teglarinad chloride (GMX-1777)

Telaprevir (VX-950)

Telatinib ( Tanespimycin) (Hsp90 inhibitor)

Telcagepant

Telicoplanin

Temoporfin

Temoporfin (PDT photosensitizer)

Temozolomide

Temsirolimus

Temsirolimus

Teniposide

Terameprocol (transcriptional inhibitor)

Tesetaxel (DJ-927)

Tesmilifene

Testolactone

Tetrandrine

TG-0054 (CXCR4 antagonist)

TG02 (multi-kinase inhibitor of CDKs, JAK2 and FLT3)

TG100-115 (PI3K inhibitor)

TG101348 ( JAK2 inhibitor)

TGX-221 (PI3K inhibitor)

TH-302 (hypoxia-activated prodrug)

TH-9402

Thalidomide

Thiarabine

Thioguanine

Thiotepa

Thymalfasin

Thymalfasin

Thymectacin (NB-1011).

Ticagrelor

Tigapotide

Tigecycline

Timcodar (VX-853)

Tipifarnib (farnesyl transferase inhibitor)

Tipranavir

Tirapazamine (hypoxia toic agent)

Tivantinib (ARQ-197) (c-Met inhibitor)

Tivozanib (AV-951) (VEGFR inhibitor)

TL-310 (a taxane)

TL32711 (Smac mimetic)

Toceranib (SU11654) (Hsp90 inhibitor)

Tofacitinib (CP-690550) (JAK inhibitor)

Topotecan Hydrochloride

Toremifene

Toremifene Citrate

Tosedostat

Tosedostat

Totrombopag

Tozasertib (MK-0457; VX-680) (Aurora inhibitor)

TPI-287 (ARC-100)

TPT-260

Trabectedin

Trabectedin

Trametinib (GSK-1120212, JTP-74057) (MEK 1/2 inhibitor)

TRC093 (a humanized IgG1 monoclonal antibody)

TRC105 (human chimeric monoclonal antibody )

Treosulfan

Tretazicar (DNA alkylating agent)

Tretinoin

Triapine (ribonucleotide reductase inhibitor)

Triciribine (VQD-002) (Akt inhibitor)

Trilostane

Trilostane

Triphendiol

Triptorelin

Tropisetron

Troxacitabine

TRX-518 (fully humanized IgG1 anti-huGITR Mab)

TST-88 (also see TST-10088, a recombinant protein prodrug based on a plant-derived toxin called ricin)

TSU-68

Tubacin (HDAC6 inhibitor)

Tubastatin-A  (HDAC6 inhibitor)

TV-1001 (Custiren, OCX-011) [a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties.]

TXA127 (heptapeptide COX-2 inhibitor)

U0126 (MEK inhibitor; MAP kinase inhibitor)

U3-1565 (anti-HBEGF monoclonal antibody)

Ukrain

UNBS-5162

Uracil

Uramustine (Uracil Mustard)

Uridine triacetate

Ursodeoxycholic acid ( Ursodiol)

Ursodiol ( Ursodeoxycholic acid)

V503 (human papillomavirus vaccine)

V935 (hTERT vaccine)

Vadimezan (AS-404; DMXAA) (vascular disrupting agent)

Valrubicin

Valspodar

Vandetanib (approved in 2011)

Vandetanib (approved in 2011) (VEGFR and EGFR inhibitor)

Vargatef

Varlitinib ( ARRY-543)

Vatalanib (VEGFR inhibitor)

VEL-0230 (NC-2300)

Veliparib ( ABT-888) (PARP inhibitor)

Vemurafenib

Vemurafenib (RG7204, PLX4032, RO5185426) (B-Raf inhibitor)

Verteporfin

Verteporfin (PDT photosensitizer)

Verubulin (MPC-6827)

Vestipitant

Vildagliptin

Vinblastine

Vincristine Sulfate

Vindesine

Vinflunine

Vinorelbine tartrate

Virulizin (A natural biological response modifier (BRM) isolated from bovine reticuloendothelial tissue).

Vismodegib (RG3616, GDC-0449) (Hedgehog antagonist)

Volasertib ( BI-6727) (Plk1 inhibitor)

Voreloxin (SNS-595, Vosaroxin)

Vorinostat

Vosaroxin (Voreloxin, SNS-595)

VP-701 (not available)

VTX-2337

VX-222

VX-689 (MK-5108)

VX-702 (p38 MAPK Inhibitor)

VX-745

VX-765 (Caspase inhibitor)

VX-770

WK-X-34 (P-glycoprotein inhibitors)

WYE-354 (mTOR inhibitor)

WZ4002 (EGFR inhibitor)

X-82

Xaliproden

Xen-2174 (conopeptide analog)

XL019 (JAK2 Inhibitor)

XL139 (BMS-833923)

XL147 (SAR-245408) (PI3K inhibitor)

XL228

XL281 (  BMS-908662)

XL647 (EGFR and ErbB2 inhibitor)

XL765 (SAR-245409) (PI3K/mTOR inhibitor)

XL888 (Hsp90 inhibitor)

XL999 (Spectrum Selective Kinase Inhibitor)

XMT-1001

XMT-1107

XR9051 (P-glycoprotein inhibitors)

YM-155 (Survivin inhibitor)

Zibotentan (AZD-4054,  ZD4054)

ZM447439

Zoledronic Acid

Zosuquidar (P-glycoprotein inhibitor)

ZSTK474 (PI3K inhbitor)

ZYC-300 (A plasmid DNA)

 

 

 

 

 

 

 

Contact MedKoo:

Email: sales@medkoo.com

 

(Keyword; CAS#; MedKoo code#)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

© MedKoo Biosciences. All Rights Reserved

 

 

Hit Counter